Abstract 20-Hydroxyeicosatetraenoic acid (20-HETE), a cytochrome P450 arachidonic acid metabolite, has been shown to modulate the growth of vascular smooth muscle cells (VSMCs). We asked whether 20-HETE modulates the proliferation of R22D cells, a clonal VSMC from neonatal rats, by releasing transforming growth factor-b (TGF-b). Incubation of R22D cells with 20-HETE for 24 h attenuated 
-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P450 metabolite of arachidonic acid (1) that plays an important role in the regulation of vascular (2-4) and renal (5-7) function. 20-HETE may act as a potent vasoconstrictor by inhibiting Ca 21 -activated K 1 channels (8) and increasing the conduction of L-type Ca 21 channels (9) . In contrast, 20-HETE may be converted by cyclooxygenase to prostaglandins and act as a vasodilator (10) (11) (12) .
In kidney, 20-HETE induces diuresis by inhibiting Na 1 -K 1 -ATPase in proximal tubules (13) and Na
1

/K
1 /Cl 2 cotransporter in the thick ascending limb of Henle's loop (5) (6) (7) .
In addition, 20-HETE may regulate cell growth. It has been demonstrated that 20-HETE stimulated DNA synthesis in epithelial cells (14) , mesangial cells (15) , fibroblasts (16) , and vascular smooth muscle cells (VSMCs) (17) . In cultured VSMCs from adult rabbit (18) and rat (17) as well as in isolated renal arterioles (3), 20-HETE induces the phosphorylation of extracellular regulated protein kinase 1/2 (ERK 1/2), a mitogen-activated protein kinase that plays a pivotal role in the proliferation induced by the activation of receptor tyrosine kinases and G protein-coupled receptors (19) . Blockade of the formation of 20-HETE attenuated norepinephrine-induced (18) and angiotensin II-induced (20) ERK 1/2 phosphorylation, suggesting that 20-HETE may serve as a second messenger of these growth factors.
Recent studies indicate that the secretion, activity, and clearance of transforming growth factor-b (TGF-b) can be regulated by long-chain polyunsaturated fatty acids such as eicosapentaenoic acid (EPA) (21, 22) . EPA inhibits plateletderived growth factor (PDGF)-induced DNA synthesis by stimulating the secretion of TGF-b in mesangial cells (21) . In addition, fatty acids may attenuate TGF-b clearance and thus increase TGF-b activity (22) . Although fatty acids have been shown to modulate the secretion, activity, and clearance of TGF-b, it is not known whether 20-HETE may modulate TGF-b availability and subsequently modulate cell growth.
In blood vessel walls, TGF-b 1 , the major isoform of TGF-b, is secreted in a latent, inactive form that binds to latent TGF binding protein (LTBP) with binding sites for extracellular matrix (ECM) (23) . The matrix-bound latent molecule may be secreted and/or activated when LTBP is proteolytically cleaved by a protease such as plasmin or matrix metalloprotease (MMP) (23) . In VSMCs, TGF-b may exert a growth-inhibitory effect by inducing cell cycle arrest at G1 phase (24) , which may be attributable to the attenuation of cyclin D, cyclin E, and cyclindependent kinases (CDKs) 2, 4, and 6 (25, 26) . In contrast, TGF-b may stimulate cell growth in VSMCs (27, 28) . These discrepancies may be the result of differences in VSMC phenotype (27, 29) and the concentration of TGF-b in VSMCs (28) . In this study, we tested the hypothesis that TGF-b may mediate the effect of 20-HETE on modulating cell proliferation in VSMCs. We demonstrated that TGF-b may mediate the inhibitory effect of 20-HETE on the growth of VSMCs from neonatal rat or human.
MATERIALS AND METHODS
Materials
20-HETE (in ethanol) purchased from Cayman Chemical Co. (Ann Arbor, MI) was dried under N 2 gas and then resuspended in the serum-free medium before use; an equal volume of serumfree medium was used as vehicle. Antibodies against cyclin D1, phospho-ERK 1/2, and phospho-MAPK/ERK kinase (MEK) were purchased from Cell Signaling Technology (Beverly, MA). Rabbit polyclonal IgGs against CDK4, b-actin, and GAPDH were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Indomethacin and tryptose phosphate broth were purchased from Sigma-Aldrich (St. Louis, MO). Paxilline was from Alomone Labs (Jerusalem, Israel). PDGF B/B was purchased from Roche (Mannheim, Germany). Recombinant human TGF-b 1 , monoclonal anti-TGF-b (TGF-b 1 , 2 , 3 ), mouse IgG isotype control, anti-human TGF-b RII antibody, and the TGF-b immunoassay kit were purchased from R&D Systems (Minneapolis, MN).
Cell culture
R22D cells, a primary culture of VSMCs isolated from neonatal rats, were established and selected for abundant production of elastin by Peter A. Jones (30) . VSMCs with a heterogeneous phenotype were isolated from aortas of neonatal Sprague-Dawley rats as described previously (31) . Human VSMCs were cultured from explants of thoracic aorta media. All cells were maintained under 5% CO 2 in minimum essential medium with penicillinstreptomycin (1%), tryptose phosphate broth (2%), and fetal bovine serum (FBS) (10% or 20% for cells from rat vs. human). In most of the experiments, cultured VSMCs were made quiescent by incubation with serum-deprived medium containing transferrin (5 mg/ml) and BSA (0.05%) for 24 h. In one experiment, R22D cells were seeded on a 24-well plate at 6,000 per well in growth medium overnight and then in serum-free medium for 24 h. PDGF (5 ng/ml) was added to each well in the presence or absence of 20-HETE (5 mM). After 1-6 days, cells from quadruplicate wells were trypsinized and counted using a hemocytometer.
RNA extraction and quantitative real-time PCR
Quiescent R22D cells were incubated for different time periods on six-well plates with 20-HETE, washed with phosphatebuffered saline, and extracted using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. Reverse transcriptase reaction was carried out using Moloney murine leukemia virus reverse transcriptase (Invitrogen). Total RNA was added to a reaction mixture containing oligo-deoxythymidine (0.5 mg/ml), dNTP (20 mM), dithiothreitol (0.1 M), Tris-HCl (250 mM, pH 8.3), KCl (375 mM), and MgCl 2 (15 mM). The reaction was conducted for 90 min at 37jC. Quantitative realtime PCR was carried out with a sequence detection system (ABI PRISM 7000; Applied Biosystems) in reaction mixture containing 13 Smart Quant Green Master Mix (Protech Technology, Enterprise), RNA (50 ng), and the following primers: sense (5 ¶-GCCCTGGATACCAACTACTGCT-3 ¶) and antisense (5 ¶-AGGCT-CCAAATGTAGGGGCAGG-3 ¶) for TGF-b 1 and sense (5 ¶-GTAA-CCCGTTGAACCCCATT-3 ¶) and antisense (5 ¶-CCATCCAATCG-GTAGTAGCG-3 ¶) for 18S rRNA. The reactions were performed with preliminary denaturation for 10 min to activate DNA polymerase, followed by 40 cycles of denaturation at 95jC for 15 s, and annealing/extension at 60jC for 1 min. All PCRs were done in duplicate on the same 96-well plate. For quantification, the threshold of cycle method was used to calculate relative fold changes normalized against the 18S RNA.
Western blot
Confluent cells were cultured in serum-free medium for 24 h before incubation with 20-HETE at the indicated times.
In some experiments, cells were exposed to FBS (10%) or PDGF (5 ng/ml) at the indicated times with or without administration of 20-HETE (5 mM). For cyclin D1 and CDK4, cells were exposed to 20-HETE (5 mM), 20-HETE plus FBS (10%), or 20-HETE plus PDGF (5 ng/ml) in the presence or absence of anti-TGF-b antibody for 12 h. Total protein of each sample was loaded onto 10% SDS-polyacrylamide gels and separated by electrophoresis for 2 h. The protein samples were transferred to nitrocellulose membranes in a transfer buffer. The membranes were washed three times with TTBS solution (containing 1% Tween 20, Tris base 50 mM, and NaCl 150 mM), incubated overnight with antibody against cyclin D1, CDK4, phospho-ERK 1/2, phospho-MEK (1:2,000), total ERK 1/2, GAPDH, and actin (1:5,000) at 4jC, and then incubated with peroxidase-conjugated secondary antibody (1:5,000) for 1 h. An ECL detection system (Perkin-Elmer, Boston, MA) was used for detection.
[ 3 H]thymidine incorporation
Cells were grown to confluence on 24-well plates before administration of concentrations of 20-HETE in growth or serum-free medium. In some experiments, quiescent cells were stimulated with PDGF (5 ng/ml) in the presence or absence of 20-HETE (5 mM). In other experiments, quiescent R22D cells were exposed to 20-HETE in the presence of TGF-b neutralizing antibody, anti-TGF-b RII antibody, or nonspecific IgG. After incubation for 18 h, 1 mCi/ml [ 3 H]thymidine was added to the culture medium and incubated for an additional 6 h. Cells were then washed three times with ice-cold phosphate-buffered saline, precipitated with ice-cold 15% trichloroacetic acid overnight, lysed with 1 N NaOH, and incubated at room temperature for at least 30 min. The radioactivity of incorporated [ 
Assay of TGF-b
Confluent R22D cells were made quiescent for 24 h before treatment with 20-HETE (5 mM) at the indicated times. Conditioned media were collected and frozen at 220jC until assay. The concentration of total TGF-b 1 (latent 1 active) in each sample was determined by a Quantikine TGF-b immunoassay kit from R&D Systems. 
Lactate dehydrogenase assay
Confluent R22D cells were made quiescent for 24 h before treatment with 20-HETE (5 or 10 mM) or H 2 O 2 (10 mM) for 24 h.
Analysis of data
All values are presented as means 6 SEM and were analyzed with a t-test or ANOVA followed by Duncan's post hoc test. Statistical significance was determined as P , 0.05. (Fig. 1A) or in growth medium (Fig. 1B) ; at 5 mM, 20-HETE significantly inhibited 3 H]thymidine incorporation by 51 6 3% and 22 6 1%, from 32,513 6 1,526 and 48,317 6 2,165 cpm, respectively (n 5 4; P , 0.05). Lower concentrations of 20-HETE (10 210 to 10 27 M) did not alter the thymidine incorporation in R22D cells (n 5 4; data not shown). The inhibitory effect of 20-HETE on [ 3 H]thymidine incorporation was also observed in aortic VSMCs (Fig. 1C) ; 20-HETE (5 mM) significantly inhibited [ 3 H]thymidine incorporation by 26 6 2% (n 5 4; P , 0.05). In addition, coadministration of 20-HETE (5 mM) with PDGF (5 ng/ml) inhibited PDGF-induced [ 3 H]thymidine incorporation by 33 6 7% in R22D cells (Fig. 1D ) and by 29 6 5% in human VSMCs (Fig. 1E) . In contrast to the inhibitory effect of 20-HETE on basal levels (Fig. 1A, D (Fig. 1E ) in human VSMCs. In quiescent R22D cells, PDGF significantly increased the cell number with time, which was inhibited by coincubation with 20-HETE (5 mM) by 28% at day 5 ( Fig. 2A) . However, 24 h of exposure to 20-HETE did not alter the morphology of R22D cells (data not shown) or cause LDH release (Fig. 2B) , whereas H 2 O 2 (10 mM) induced 90 6 2% LDH release in this preparation.
RESULTS
20-HETE inhibited
DNA synthesis in VSMCs 20-HETE inhibited [ 3 H]thymidine incorporation in a concentration-dependent manner in R22D cells cultured in either serum-free medium
Anti-TGF-b antibody reversed 20-HETE-induced inhibition of DNA synthesis
Previous studies have indicated that long-chain polyunsaturated fatty acids may modulate cell growth by releasing TGF-b (21) . We asked whether 20-HETE inhibited cell proliferation by releasing TGF-b. As illustrated in Fig. 3A , anti-TGF-b antibody exhibited no effect on basal (Fig. 3B) . These results suggested that the inhibitory effect of 20-HETE may be mediated by TGF-b in R22D cells. As revealed by ELISA, the concentration of TGF-b 1 in the condition medium collected from the cells treated with 20-HETE (5 mM) for both 12 and 24 h was higher than that of vehicle-treated cells (Fig. 3C) . After 24 h of treatment with 20-HETE, TGF-b 1 secretion was 45% higher than that of the vehicle group, which corresponds to 237 6 26 pg/ml more secreted TGF-b 1 in the medium. However, the mRNA expression of TGF-b 1 was not affected by 3 to 24 h of exposure to 5 mM 20-HETE, as revealed by quantitative real-time PCR (Fig. 3D) .
Previous work has shown that 20-HETE may be further converted by cyclooxygenase to biologically active metabolites (10) (11) (12) . However, pretreatment of indomethacin, a cyclooxygenase inhibitor, did not affect the growth-inhibitory effect of 20-HETE (Fig. 3E) . In addition, 20-HETE may induce vasoconstriction by inhibiting the Ca 21 -activated K 1 channel (8). Nevertheless, pretreatment with paxilline, a K 1 channel inhibitor, did not affect the inhibitory effect of 20-HETE either (Fig. 3E) .
To determine whether an additional 200 pg/ml TGF-b 1 may exert an inhibitory effect on DNA synthesis in R22D 
20-HETE inhibited FBS-or PDGF-induced cyclin D1 expression
It has been established that TGF-b inhibits [ 3 H]thymidine incorporation via the downregulation of cyclin D1 expression (26, 32) . In a representative result illustrated in Fig. 5 , 20-HETE attenuated FBS-and PDGF-induced cyclin D1 expression by 23% and 30%, which averaged 32 6 7% (n 5 4; P , 0.05) and 44 6 5% (n 5 3; P , 0.05) in repeated studies, respectively. Anti-TGF-b antibody exhibited no effect on basal cyclin D1 expression but completely reversed the inhibitory effect of 20-HETE on FBS-and PDGF-induced cyclin D1 expression (P , 0.05). Nevertheless, nonspecific IgG exhibited no effect on either basal cyclin D1 expression or the inhibitory effect of 20-HETE. In contrast, the expression of CDK4 or actin remained stable irrespective of different treatments.
20-HETE did not affect the phosphorylation of MEK or ERK 1/2
It has been reported that 20-HETE may mediate the mitogen-induced ERK 1/2 phosphorylation and may increase the kinase activity of ERK 1/2 (3, 17, 18) . We asked whether 20-HETE inhibited DNA synthesis by inhibiting ERK 1/2 phosphorylation in R22D cells. As illustrated in Fig. 6A , 5 mM 20-HETE did not affect MEK or ERK 1/2 phosphorylation levels at 2-60 min after the addition of 20-HETE. FBS (Fig. 6B) or PDGF (Fig. 6C) induced a transient increase of ERK 1/2 phosphorylation, whereas pretreatment of 20-HETE did not affect the FBS-or PDGFinduced phosphorylation of MEK and ERK 1/2. In addition, 20-HETE did not cause the phosphorylation of p38 or JNK in R22D cells (n 5 3; data not shown).
DISCUSSION
In the present study, we demonstrated that 20-HETE inhibited the proliferation of VSMCs from neonatal rat and human. To our knowledge, this is the first report dem- It is unclear how 20-HETE increases TGF-b secretion into the culture medium. Nevertheless, it is unlikely that 20-HETE increases the transcription of TGF-b, because TGF-b mRNA expression was not affected by 20-HETE. Alternatively, the secretion of TGF-b may be increased by an enhanced MMP activity (33) . In fact, TGF-b may be released by a polyunsaturated fatty acid such as EPA (21); however, EPA has been shown to inhibit, not increase, MMP activity (34) . Overall, it seems unlikely that 20-HETE increased MMP activity to enhance the secretion of TGF-b, because most polyunsaturated fatty acids either inhibit or exert no effect on MMP activity (34) . Alternatively, interference with the interaction of TGF-b, LTBP, and ECM may cause an enhanced secretion of TGF-b (23). Although fatty acids have been demonstrated to inhibit the complex formation of TGF-b and a plasma protein (22) , it remains to be determined whether 20-HETE may exert an inhibitory effect on the complex formation of TGF-b with LTBP, decrease the sequestration of latent TGF-b complex into ECM, and subsequently increase the TGF-b concentration in the culture medium. However, we cannot rule out other possibilities for the modulation of TGF-b release from ECM, because fatty acids may modulate the composition of ECM (35) (36) (37) .
In contrast to our finding that 20-HETE inhibited DNA synthesis in VSMCs, a previous study demonstrated that 20-HETE may increase DNA synthesis in VSMCs from aorta of adult rats (17) . Because TGF-b is a pleiotropic growth factor that may either promote (28) or inhibit (24) the growth of VSMCs, TGF-b may play a role in causing the pleiotropic effects of 20-HETE. In aortic VSMCs, we have shown that lower concentrations of TGF-b 1 stimulated but higher concentrations inhibited DNA synthesis (Fig. 4B) , consistent with a previous finding in VSMCs (28) . However, 20-HETE did not stimulate growth in the aortic VSMC preparation (Fig. 1C) , probably because that exogenously added authentic TGF-b may not fully mimic the kinetics and the process of TGF-b release in response to 20-HETE. Nevertheless, the amount of TGF-b secreted may be a switch in the regulation of VSMC growth by 20-HETE. Furthermore, the effect of 20-HETE on cell proliferation may depend on VSMC phenotype (27) . It has been demonstrated that TGF-b may exert a concentrationdependent growth-inhibitory effect in spindle-shaped cells but a growth-stimulatory effect at low concentrations in the epithelioid phenotype (27) . 20-HETE may exert different effects on DNA synthesis, depending on both the amount of TGF-b secreted and the phenotype of VSMCs.
In conclusion, our study demonstrates that the growthinhibitory effect of 20-HETE may be mediated by enhancing TGF-b secretion in VSMCs. Our results provide a novel mechanism of 20-HETE in the regulation of VSMC proliferation.
